MAP1LC3A and breast cancer: To further demonstrate the specificity of autophagy blockade in eliminating dormant BC cells, D2.0 R cells labelled with mCherry-EGFP-LC3 were tail vein injected in mice 3 weeks after nasal instillation with Ad-empty or Ad-TGFβ223/225 (Methods and Supplementary Fig. 7).